You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 20, May 27, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Psychiatry
 •Depression
 •Tobacco
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antidepressant Treatment and Smoking Cessation in Bipolar Disorder

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In his Clinical Crossroads discussion of a 51-year-old woman with bipolar disorder who wants to quit smoking, Dr Schroeder1 indicated that bupropion should be considered for smokers with chronic depression because it may benefit the depression as well as help with smoking cessation. However, this point is controversial in patients with bipolar disorders because of questions about efficacy and the risk of precipitating mania.

Bupropion, used to reduce tobacco smoking, is also widely used as an antidepressant. In a 26-week double-blind, placebo-controlled study in patients with bipolar depression,2 the use of standard antidepressant medication (including bupropion) as adjuncts to mood stabilizers was not associated with increased efficacy compared with the use of mood stabilizers alone; in addition, there was no increased risk of treatment-emergent affective switch. In randomized trials of bupropion, sertraline, or venlafaxine as an adjunct to a mood stabilizer,3 acute antidepressant augmentation was associated with . . . [Full Text of this Article]

Alain Dervaux, MD
a.dervaux@ch-sainte-anne.fr

Xavier Laqueille, MD
Service d’Addictologie
Centre Hospitalier Sainte-Anne
Paris, France



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

A 51-Year-Old Woman With Bipolar Disorder Who Wants to Quit Smoking
Steven A. Schroeder
JAMA. 2009;301(5):522-531.
ABSTRACT | FULL TEXT  

RELATED LETTER

Antidepressant Treatment and Smoking Cessation in Bipolar Disorder—Reply
Steven A. Schroeder
JAMA. 2009;301(20):2093.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.